Skip to Main Content

Author Details

Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
2005
102
36
PMIDPaper TitleJournal TitlePublished Year
37213686The complete reference genome for grapevine (<i>Vitis vinifera</i> L.) genetics and breeding.Hortic Res2023
37556934Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.Gynecol Oncol2023
37452083Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer.Cancer Gene Ther2023
35082166Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical Implications.Mol Cancer Res2022
35563856Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer.Cells2022
35064078Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells.Proc Natl Acad Sci U S A2022
33038264GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells.Int J Cancer2021
33793068The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms.Mol Oncol2021
33568749ZRSR2 overexpression is a frequent and early event in castration-resistant prostate cancer development.Prostate Cancer Prostatic Dis2021
33890165Computer-aided superimposition of the frontal sinus via 3D reconstruction for comparative forensic identification.Int J Legal Med2021
34279968Broadband Plasmon-Enhanced Four-Wave Mixing in Monolayer MoS<sub>2</sub>.Nano Lett2021
33240433Fatty acid synthase promotes breast cancer metastasis by mediating changes in fatty acid metabolism.Oncol Lett2021
33070282Morphological analysis of three-dimensionally reconstructed frontal sinuses from Chinese Han population using computed tomography.Int J Legal Med2021
32451180Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer.Eur Urol2020
33171818Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity.Int J Mol Sci2020
32598130Electrical Control of Interband Resonant Nonlinear Optics in Monolayer MoS<sub>2</sub>.ACS Nano2020
32462533The dominant model analysis of Sirt3 genetic variants is associated with susceptibility to tuberculosis in a Chinese Han population.Mol Genet Genomics2020
32512818Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development.Cells2020
30274982Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer.Clin Cancer Res2019
31559706The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer.EMBO Mol Med2019
30776192The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program.Mol Oncol2019
30706932High photoresponsivity and broadband photodetection with a band-engineered WSe<sub>2</sub>/SnSe<sub>2</sub> heterostructure.Nanoscale2019
31169331Vascular endothelial growth factor (VEGF) impairs the motility and immune function of human mature dendritic cells through the VEGF receptor 2-RhoA-cofilin1 pathway.Cancer Sci2019
30402703Forensic age estimation for pelvic X-ray images using deep learning.Eur Radiol2019
30655535ONECUT2 is a driver of neuroendocrine prostate cancer.Nat Commun2019
29487201Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer.Cancer Res2018
29915181Integrated microRNA and mRNA expression profiling reveals a complex network regulating pomegranate (Punica granatum L.) seed hardness.Sci Rep2018
30073676Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.Prostate2018
30210643Inhibition of Transient Receptor Potential Vanilloid 6 channel, elevated in human ovarian cancers, reduces tumour growth in a xenograft model.J Cancer2018
29905005Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer.Cancer Med2018
30120285Complementary iTRAQ-based proteomic and RNA sequencing-based transcriptomic analyses reveal a complex network regulating pomegranate (Punica granatum L.) fruit peel colour.Sci Rep2018
30067694Active synchronization and modulation of fiber lasers with a graphene electro-optic modulator.Opt Lett2018
30259010Photoresponse of Graphene-Gated Graphene-GaSe Heterojunction Devices.ACS Appl Nano Mater2018
28330676Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.Eur Urol2018
29441566Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model.Int J Cancer2018
29381682Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer.Br J Cancer2018
29544736Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.Eur Urol2018
27180064SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition.Eur Urol2017
28460430Metabolic heterogeneity signature of primary treatment-naïve prostate cancer.Oncotarget2017
28594931De novo transcriptome assembly and quantification reveal differentially expressed genes between soft-seed and hard-seed pomegranate (Punica granatum L.).PLoS One2017
28878788Transcriptomic Analysis Reveals Candidate Genes for Female Sterility in Pomegranate Flowers.Front Plant Sci2017
28642484miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer.Sci Rep2017
28846697Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation.PLoS One2017
28864460A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents.Cold Spring Harb Mol Case Stud2017
27663589<i>BIRC6</i> Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer.Clin Cancer Res2017
26755530The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer.Clin Cancer Res2016
26547391Subrenal capsule grafting technology in human cancer modeling and translational cancer research.Differentiation2016
27809226Biophysical Properties and Motility of Human Mature Dendritic Cells Deteriorated by Vascular Endothelial Growth Factor through Cytoskeleton Remodeling.Int J Mol Sci2016
27449197The evolution mechanism of intron length.Genomics2016
26809501Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression.Mol Oncol2016
  • 1 - 50 of 102

Recommended Authors

Yaser Gamallat
Cumming School of Medicine, University of Calgary
Career Start Year 2016
Number of shared co-authors 2
Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Minhyung Kim
Roswell Park Comprehensive Cancer Center
Career Start Year 2010
Number of shared co-authors 6
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 5
Rahul Kumar
Roswell Park Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 2
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 18
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 2
Young K Song
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Jonathan Chou
University of California san francisco
Career Start Year 2005
Number of shared co-authors 23
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 10
Yongwei Yu
Changhai Hospital
Career Start Year 2001
Number of shared co-authors 12
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 19
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 1
Ming Zhan
Ningbo First Hospital, Zhejiang University
Career Start Year 2000
Number of shared co-authors 0
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 2
Kristiina Iljin
VTT Technical Research Centre of Finland Ltd
Career Start Year 1999
Number of shared co-authors 0
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 3
Feng Zhu
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 1
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 1
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 19
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 10
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 8
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 13
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 5
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 36
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 45
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 24

Collaborators

Yuzhuo Wang
University of British Columbia
Co-authored papers 54
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Co-authored papers 36
Colin C Collins
University of British Columbia
Co-authored papers 34
Martin E Gleave
University of British Columbia
Co-authored papers 23
Anne Haegert
University of British Columbia
Co-authored papers 15
Ladan Fazli
University of British Columbia
Co-authored papers 11
Xinpei Ci
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 11
Fan Mo
Institute of Stem Cell and Regeneration, Chinese Academy of Sciences
Co-authored papers 8
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 8
Robert H Bell
University of British Columbia
Co-authored papers 7
Alexander W Wyatt
University of British Columbia
Co-authored papers 6
Cyril B Gilks
University of British Columbia
Co-authored papers 5
Wan L Lam
British Columbia Cancer Research Institute
Co-authored papers 5
Stanislav V Volik
University of British Columbia
Co-authored papers 5
Mark A Rubin
University of Bern
Co-authored papers 5
Amina Zoubeidi
University of British Columbia
Co-authored papers 5
David G Huntsman
University of British Columbia
Co-authored papers 5
Sonal Brahmbhatt
University of British Columbia
Co-authored papers 5
Shawn Anderson
University of British Columbia
Co-authored papers 4
Akira Watahiki
Co-authored papers 3
Jane Bayani
Ontario Institute for Cancer Research
Co-authored papers 3
Larissa A Pikor
Ottawa Hospital Research Institute
Co-authored papers 3
Francesca Demichelis
University of Trento
Co-authored papers 3
Antonio Hurtado-Coll
University of British Columbia
Co-authored papers 3
Kim N Chi
University of British Columbia
Co-authored papers 3
Jeremy A Squire
University of Sao Paulo
Co-authored papers 3
Varune R Ramnarine
University of British Columbia
Co-authored papers 2
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 2
David S Rickman
Meyer Cancer Center
Co-authored papers 2
David Wilkes
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers 2
Release 1.2